These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation. Su Y; Fu J; Yu J; Zhao Q; Guan Y; Zuo C; Li M; Tan H; Cheng X J Alzheimers Dis; 2020; 76(1):149-157. PubMed ID: 32444551 [TBL] [Abstract][Full Text] [Related]
4. Closing the tau loop: the missing tau mutation. McCarthy A; Lonergan R; Olszewska DA; O'Dowd S; Cummins G; Magennis B; Fallon EM; Pender N; Huey ED; Cosentino S; O'Rourke K; Kelly BD; O'Connell M; Delon I; Farrell M; Spillantini MG; Rowland LP; Fahn S; Craig P; Hutton M; Lynch T Brain; 2015 Oct; 138(Pt 10):3100-9. PubMed ID: 26297556 [TBL] [Abstract][Full Text] [Related]
6. Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features. Ikeda A; Shimada H; Nishioka K; Takanashi M; Hayashida A; Li Y; Yoshino H; Funayama M; Ueno Y; Hatano T; Sahara N; Suhara T; Higuchi M; Hattori N Mov Disord; 2019 Apr; 34(4):568-574. PubMed ID: 30773680 [TBL] [Abstract][Full Text] [Related]
7. Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation. Morino H; Kurashige T; Matsuda Y; Ono M; Sahara N; Miyasaka T; Soeda Y; Shimada H; Yamazaki Y; Takahashi T; Izumi Y; Ito H; Maruyama H; Higuchi M; Arihiro K; Suhara T; Takashima A; Kawakami H Mov Disord Clin Pract; 2024 Jun; 11(6):720-727. PubMed ID: 38605589 [TBL] [Abstract][Full Text] [Related]
8. 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset. Wu L; Liu J; Feng X; Dong J; Qin W; Liu Y; Wang J; Lu J; Chen K; Wang Y; Jia J J Alzheimers Dis; 2018; 61(2):613-618. PubMed ID: 29226866 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy. Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539 [TBL] [Abstract][Full Text] [Related]
10. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia. Momeni P; Wickremaratchi MM; Bell J; Arnold R; Beer R; Hardy J; Revesz T; Neal JW; Morris HR Clin Neurol Neurosurg; 2010 Dec; 112(10):917-20. PubMed ID: 20708332 [TBL] [Abstract][Full Text] [Related]
11. In Vivo Zhou XY; Lu JY; Liu FT; Wu P; Zhao J; Ju ZZ; Tang YL; Shi QY; Lin HM; Wu JJ; Yen TC; Zuo CT; Sun YM; Wang J Mov Disord; 2022 Mar; 37(3):525-534. PubMed ID: 34842301 [TBL] [Abstract][Full Text] [Related]
12. Clinical and neuroimaging characterization of the first frontotemporal dementia family carrying the MAPT p.K298E mutation. Pozzi FE; Aprea V; Giovannelli G; Lattuada F; Crivellaro C; Bertola F; Castelnovo V; Canu E; Filippi M; Appollonio I; Ferrarese C; Agosta F; Tremolizzo L Neurogenetics; 2024 Jul; 25(3):215-223. PubMed ID: 38592608 [TBL] [Abstract][Full Text] [Related]
13. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Whitwell JL; Weigand SD; Boeve BF; Senjem ML; Gunter JL; DeJesus-Hernandez M; Rutherford NJ; Baker M; Knopman DS; Wszolek ZK; Parisi JE; Dickson DW; Petersen RC; Rademakers R; Jack CR; Josephs KA Brain; 2012 Mar; 135(Pt 3):794-806. PubMed ID: 22366795 [TBL] [Abstract][Full Text] [Related]
14. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)]. Kowalska A Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823 [TBL] [Abstract][Full Text] [Related]
15. Synaptic gene expression changes in frontotemporal dementia due to the MAPT 10 + 16 mutation. Dando O; McGeachan R; McQueen J; Baxter P; Rockley N; McAlister H; Prasad A; He X; King D; Rose J; Jones PB; Tulloch J; Chandran S; Smith C; Hardingham G; Spires-Jones TL Neuropathol Appl Neurobiol; 2024 Aug; 50(4):e13006. PubMed ID: 39164997 [TBL] [Abstract][Full Text] [Related]
16. 18F-MK-6240 tau-PET in genetic frontotemporal dementia. Levy JP; Bezgin G; Savard M; Pascoal TA; Finger E; Laforce R; Sonnen JA; Soucy JP; Gauthier S; Rosa-Neto P; Ducharme S Brain; 2022 Jun; 145(5):1763-1772. PubMed ID: 34664612 [TBL] [Abstract][Full Text] [Related]
17. A Peculiar Tau Accumulation Pattern Identified Via 18 F-Florzolotau PET Imaging in a Patient With Frontotemporal Dementia Caused by a Mutation in the MAPT Gene. Li Q; Li H; Huang Z; Li Y; Cui R Clin Nucl Med; 2024 Oct; 49(10):995-996. PubMed ID: 39010313 [TBL] [Abstract][Full Text] [Related]
18. Familial tauopathy with P364S MAPT mutation: clinical course, neuropathology and ultrastructure of neuronal tau inclusions. Štrafela P; Pleško J; Magdič J; Koritnik B; Zupan A; Glavač D; Bresjanac M; Popović M Neuropathol Appl Neurobiol; 2018 Oct; 44(6):550-562. PubMed ID: 29215752 [TBL] [Abstract][Full Text] [Related]
19. Two pathologically confirmed cases of novel mutations in the MAPT gene causing frontotemporal dementia. Shafei R; Woollacott IOC; Mummery CJ; Bocchetta M; Guerreiro R; Bras J; Warren JD; Lashley T; Jaunmuktane Z; Rohrer JD Neurobiol Aging; 2020 Mar; 87():141.e15-141.e20. PubMed ID: 31870644 [TBL] [Abstract][Full Text] [Related]
20. Characterizing the Clinical Features and Atrophy Patterns of Young AL; Bocchetta M; Russell LL; Convery RS; Peakman G; Todd E; Cash DM; Greaves CV; van Swieten J; Jiskoot L; Seelaar H; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Sorbi S; Williams SCR; Alexander DC; Rohrer JD; Neurology; 2021 Aug; 97(9):e941-e952. PubMed ID: 34158384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]